May 6, 2026
1 min read

The timing is right for psychedelics manufacturer Optimi Health’s IPO

Last month, when Optimi Health kicked off an initial public offering of 2.5 million shares, the timing couldn’t have been better for the Vancouver-based manufacturer of psychedelic drugs. With President Donald Trump recently signing an executive order to accelerate research and ease the restrictions on psychedelics, there is unprecedented buzz around the potential of the hallucinogenic drugs to treat mental disorders.

Leave a Reply

Your email address will not be published.

Previous Story

HHS’ Healthy Food Agenda Puts Hospitals On Notice About Patients’ Meals MedNews

Next Story

Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds MedNews

Previous Story

HHS’ Healthy Food Agenda Puts Hospitals On Notice About Patients’ Meals MedNews

Next Story

Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds MedNews

Latest from Blog

Go toTop